BETA
Beta Drugs Limited
Pharmaceuticals
Share price
₹2,328
Market cap
₹1,417 Cr
1Y return
▲ 21%
A pharmaceutical manufacturer specializing in oncology drugs, Beta Drugs Ltd produces a comprehensive range of anti-cancer medications serving patients across India and international markets. The company operates through both domestic and export channels, distributing its products to institutional buyers, hospitals, and retail segments within the healthcare sector. Its focused expertise in oncology therapeutics and manufacturing capabilities position it within the critical healthcare segment addressing cancer treatment needs across emerging and established markets worldwide.
Investors holding Beta Drugs Limited
6.13%
1.60%
Latest move
Ashish KacholiaDecreased
Ashish Kacholia reduced his stake in Beta Drugs Limited from 12.47 percent to 11.04 percent, selling 40,000 shares across his holdings.
Sign in to read more
Track the whales in Beta Drugs Limited
Get alerted the moment a top investor buys or sells.
Get started